The study
REAL compared robotic and laparoscopic surgery for middle and low rectal cancer. Among 1,171 patients in the primary analysis, three-year locoregional recurrence was 1.6% after robotic surgery and 4.0% after laparoscopy: an absolute difference of 2.4 percentage points. The hazard ratio was 0.45 (95% CI 0.22–0.92). Overall survival did not differ significantly.
Why read it
A worthwhile starting point for exploring how surgical innovation should be judged. The central question concerns outcomes that matter to patients, and the paper invites readers to examine absolute differences alongside relative estimates.
Limits & open questions
The trial involved experienced surgeons in China; results may not transfer unchanged to other teams or populations. Sixty-nine patients were excluded from the primary analysis after being found ineligible following randomization. Technique, training and case selection remain essential context.